We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

05 Aug 2026 - 07 Aug 2026
18 Aug 2026 - 20 Aug 2026
20 Aug 2026 - 22 Aug 2026

Superconducting Cyclotron Enables Year-Round Proton Treatments

By HospiMedica staff writers
Posted on 18 Apr 2007
Clinicians in Switzerland have begun clinical treatments using the world's first commercial superconducting cyclotron for routine medical use, enabling high-precision proton therapy treatments for a range of cancer patients. More...


The new cyclotron from Varian Medical Systems' (Palo Alto, CA, USA) Accel group is a major component of the equipment and is expected to facilitate more accurate treatments with fewer side effects at the Paul Scherrer Institute (PSI; Villigen, Switzerland). Two patients with chordomas (bone tumors in the spinal region) were the first to be treated using protons generated by the new 250 MeV cyclotron, which is designed for high-efficiency, low-energy consumption, high reliability, and modern treatment features such as spot scanning, enabling highly effective proton dose distribution in three dimensions, and beam-intensity modulation.

The Varian/Accel superconducting cyclotron represents a dedicated proton source for the PSI equipment, with beam-lines to supply up to 250 MeV protons to the spot-scanning gantry for deep-seated tumor treatments.
PSI operates the world's first and only compact scanning gantry for proton radiation therapy of deep-seated tumors.

The spot-scanning technique developed at PSI enables malignant tumors to be targeted with high precision deep inside in the body, and their growth successfully stopped, without damaging healthy tissue around the target area. Protons have excellent physical properties for radiation therapy, which enable clinicians to precisely control the shape of the dose distribution inside the patient's body. The depth of the proton beam can be precisely controlled, which means healthy tissue behind the tumor can be spared as effectively as adjacent tissue.

The new cyclotron would allow the institute's proton therapy facility to operate all year rather than being limited to just six-eight months, as was the case with the department's previous equipment. The Varian/Accel superconducting cyclotron, degrader, beam line, and gantries will enable PSI to maintain and enhance its international reputation as a unique high-tech laboratory for advanced proton therapy as well as a leading clinical proton therapy research center.


Related Links:
Varian Medical Systems

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.